Brentuximab vedotin as consolidation after hematopoietic cell transplant for relapsed Hodgkin lymphoma in pediatric patients.
Jamie E FlerlageXinyu von ButtlarMatthew KrasinBrandon M TriplettSue C KasteMonika L MetzgerPublished in: Pediatric blood & cancer (2019)